RMD logo
RMD NYSE US

ResMed Inc. Common Stock

Health Care · Health Care Situs Web · IPO Jun 1995
$227,44
▲ +$2,72 (+1,21%)
Vol 136K
Kap. Pasar
$32.7B
P/E
22,0
ROE
24,8%
Margin
27,5%
Beta
0,92
Imbal Hasil Dividen
1,07%
52W
$202–$294

Konsensus Wall Street

25 analis · Apr 2026
4
Beli Kuat
11
Beli
9
Tahan
0
Jual
1
Jual Kuat
60,0%
Peringkat Beli

Grafik Harga

Pendapatan

Tingkat beat: 50,0%
Kuartal EPS Estimasi EPS Aktual Kejutan
Des 2025 $2,75 $2,81 +$0,06
Sep 2025 $2,58 $2,55 $-0,03
Jun 2025 $2,51 $2,55 +$0,04
Mar 2025 $2,38 $2,37 $-0,01

Pendapatan & Laba Kuartalan

Kuartal 2024-0… 2024-1… 2025-0… 2025-0… 2025-0… 2025-1…
Pendapatan $1.3B $1.3B $1.3B $1.3B $1.4B
Laba Bersih $344.6M $365.0M $379.7M $348.5M $392.6M

Tren Fundamental

Metrik 2026-04-12 2026-04-17
ROE (TTM) 24.8% 24.8%
P/E (TTM) 22.44 22.01
Net Margin 27.5% 27.5%
Gross Margin 60.9% 60.9%
D/E Ratio
Current Ratio 3.06 3.06

Rasio Utama

ROA (TTM)
18,3%
P/S (TTM)
6,06
P/B
6,3
EPS (TTM)
$10,12
CF/Share
$7,33
Pertumbuhan Pendapatan 3T
+12,9%
52W High
$293,81
52W Low
$202,00
$202,00 Rentang 52 Minggu $293,81

Kesehatan Keuangan

Arus Kas Bebas
$305.2M
Utang Bersih
-$569.3M
Kas
$1.4B
Total Utang
$847.7M
Per tanggal Des 31, 2025

Як RMD виглядає на тлі конкурентів у Health Care?

Група порівняння: Peers · Health Care (Peers) · 10 компаній

Оцінка RMD vs аналоги Health Care

P/E
22,4
15% di bawah rekan (26,3)
vs Rekan
vs Industri
Undervalued
P/S
6,2
25% di atas rekan (4,9)
vs Rekan
vs Industri
Overvalued
P/B
6,3
20% di atas rekan (5,3)
vs Rekan
vs Industri
Lebih mahal
Дивідендна дохідність
1,1%
0% di atas rekan (1,1%)
vs Rekan
vs Industri
Yield rendah

Прибутковість RMD vs аналоги Health Care

ROE
24,8%
57% di atas rekan (15,9%)
vs Rekan
vs Industri
Tingkat atas
Net margin
27,5%
101% di atas rekan (13,7%)
vs Rekan
vs Industri
Tingkat atas
Валова маржа
60,9%
1% di bawah rekan (61,3%)
vs Rekan
vs Industri
Sejajar
ROA
18,3%
102% di atas rekan (9,0%)
vs Rekan
vs Industri
Tingkat atas

Фінансове здоровʼя RMD vs аналоги Health Care

D/E ratio
0% di bawah rekan (82,5)
vs Rekan
vs Industri
Sejajar
Поточна ліквідність
3,1
72% di atas rekan (1,8)
vs Rekan
vs Industri
Likuiditas kuat
Beta
1,0
5% di bawah rekan (1,0)
vs Rekan
vs Industri
Kurang volatil

Радар фундаменталів RMD

RMD Median rekan Industri

RMD прибутковість vs борг

Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio

RMD vs аналоги: ключові метрики

Aktivitas Orang Dalam

Bearish
Pembelian
0
Penjualan
10
$5966524
FARRELL MICHAEL J
Chief Executive Officer · Apr 07
sale
4991 shs
FARRELL MICHAEL J
Chief Executive Officer · Apr 07
conversion of exercise of derivative security
4991 shs
SANDERCOCK BRETT
Chief Financial Officer · Apr 01
sale
1000 shs
FARRELL PETER CRAIG
Director · Apr 01
sale
2000 shs
FARRELL MICHAEL J
Chief Executive Officer · Mar 09
sale
4991 shs
FARRELL MICHAEL J
Chief Executive Officer · Mar 09
conversion of exercise of derivative security
4991 shs
FARRELL PETER CRAIG
Director · Mar 04
sale
2000 shs
SANDERCOCK BRETT
Chief Financial Officer · Mar 02
sale
1000 shs
FARRELL MICHAEL J
Chief Executive Officer · Feb 09
sale
4991 shs
FARRELL MICHAEL J
Chief Executive Officer · Feb 09
conversion of exercise of derivative security
4991 shs
Terakhir 90 hari

Pemegang Terbesar

Top 5: 32,3%
Vanguard Group Inc
12,96%
$4.3B
Blackrock Inc.
8,48%
$2.8B
State Street Corporation
4,55%
$1.5B
Bank Of New York Mellon Cor…
3,36%
$1.1B
Geode Capital Management, L…
2,95%
$984.8M
Per tanggal Des 31, 2025

Dividen

$2,33
/ tahun
Feb 12, 2026 $0,6000
Nov 13, 2025 $0,6000
Agu 14, 2025 $0,6000
Mei 08, 2025 $0,5300
Feb 13, 2025 $0,5300
Nov 07, 2024 $0,5300
Agu 15, 2024 $0,5300
Mei 08, 2024 $0,4800